Kaken Pharmaceutical Co., Ltd.

¥3,740As of Sun 8 Nov 2026, 12:00 UTC
TSE:4521Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (2.10%)
Div yield 5.08%
ROE 6.87%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.08
PE TTM 13.73
TSR TTM 6.97%
Mkt cap ¥141.6B
ROIC 10.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4,192
12.09%
82.73%
Hold 11|11|1|8|5
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
42.06
40.32
41.21
42.50
11.87%
7.86%
10.77%
3.22%
Revenue¥B
10.52
10.87
11.32
11.30
3.47%
9.70%
12.62%
7.38%
Peers (US$899.2M)
Cap (US$)
PE
1.035B
19.71x
898.1M
41.23x
Capital
TTM
5Y
10Y
Leveragex
0.453
0.416
0.329
EBIT/Intx
0.954
0.480
0.443
Own earn%
(517.26)
67.97
58.66
Sh yield%
18.45
15.25
17.09
Owners
Insiders/Inst%
14.13
49.03
Short interest%
2.69
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–10
$1 testx
0.1
Incr. ROIC%
3